FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2316054119> ?p ?o ?g. }

• W2316054119 endingPage "284" @default.
• W2316054119 startingPage "251" @default.
• W2316054119 abstract "Despite the advent of new antifungal agents, coccidioidal meningitis (CM) remains a difficult-to-treat condition with significant morbidity and mortality. In this study we directly compare the clinical presentation and management of patients with Coccidioides immitis meningitis in the azole era (after 1980) to that of a cohort of patients from the pre-azole era. We reviewed 30 CM cases seen at 3 Los Angeles hospitals between the years 1993 to 2008 (2008 cohort) and compared them to 31 patients (1980 cohort) described by Bouza et al in a previous study. The demographics and clinical presentation of patients in the 2008 cohort were similar to those of the 1980 cohort except for a higher incidence of Hispanic patients (2008: 53% vs. 1980: 6%) and a greater percentage of patients with underlying, predisposing clinical conditions (2008: 66% vs. 1980: 32%). Ten patients in the 2008 cohort had human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), a condition not reported in the earlier study. Laboratory findings were similar between the 2 groups except for a lower incidence of peripheral leukocytosis and eosinophilia in the 2008 group. There were marked differences in drug treatment between the 2 eras. In the 2008 cohort, 29 patients received fluconazole therapy: 13 were treated with fluconazole monotherapy, and 16 received a combination of fluconazole and intravenous amphotericin B. Although almost all patients (29/31) in the 1980 cohort received intrathecal amphotericin B, only 3 patients in the 2008 study received amphotericin B via this route. With respect to complications of CM, a similar percentage of patients in each cohort developed complications such as stroke and hydrocephalus. The 2008 cohort (40%) had similar mortality compared to patients in the 1980 study (39%); survivors in both groups experienced significant impairment of activities of daily living. Although recommended as first-line therapy for CM, azole-based therapies are not curative and do not necessarily prevent complications associated with the disease. CM remains a serious illness with a high rate of morbidity and mortality. Immunocompromised individuals, especially those with HIV/AIDS, are at special risk for CM and represent a greater share of the overall population with this condition. Despite the clear advantages of azole treatment in CM, new therapeutic approaches are needed to provide definitive cure and to reduce the need for long-term suppressive therapy. Abbreviations: AIDS = acquired immunodeficiency syndrome, AmB D = amphotericin B desoxycholate, CF = complement fixation, CM = coccidioidal meningitis, CSF = cerebrospinal fluid, CT = computerized tomography, ELISA = enzyme-linked immunoserologic assay, HAART = highly active antiretroviral therapy, HIV = human immunodeficiency virus, IRB = institutional review board, LAmB = liposomal amphotericin B, MRI = magnetic resonance imaging, po = orally, VP = ventriculoperitoneal." @default.
• W2316054119 created "2016-06-24" @default.
• W2316054119 creator A5053787215 @default.
• W2316054119 creator A5060437184 @default.
• W2316054119 creator A5081450006 @default.
• W2316054119 creator A5091692954 @default.
• W2316054119 date "2010-09-01" @default.
• W2316054119 modified "2023-10-16" @default.
• W2316054119 title "Coccidioidal Meningitis" @default.
• W2316054119 cites W1962659169 @default.
• W2316054119 cites W1965088264 @default.
• W2316054119 cites W1965517064 @default.
• W2316054119 cites W1967879315 @default.
• W2316054119 cites W1970682121 @default.
• W2316054119 cites W1971165889 @default.
• W2316054119 cites W1977885791 @default.
• W2316054119 cites W1982083114 @default.
• W2316054119 cites W1994951476 @default.
• W2316054119 cites W2004508810 @default.
• W2316054119 cites W2011031248 @default.
• W2316054119 cites W2016227754 @default.
• W2316054119 cites W2032996105 @default.
• W2316054119 cites W2034086518 @default.
• W2316054119 cites W2042863953 @default.
• W2316054119 cites W2045554704 @default.
• W2316054119 cites W2049570643 @default.
• W2316054119 cites W2052469869 @default.
• W2316054119 cites W2059951311 @default.
• W2316054119 cites W2065870824 @default.
• W2316054119 cites W2077978841 @default.
• W2316054119 cites W2102207686 @default.
• W2316054119 cites W2105376278 @default.
• W2316054119 cites W2109415756 @default.
• W2316054119 cites W2110002304 @default.
• W2316054119 cites W2117389687 @default.
• W2316054119 cites W2122750839 @default.
• W2316054119 cites W2127436244 @default.
• W2316054119 cites W2129909105 @default.
• W2316054119 cites W2130333968 @default.
• W2316054119 cites W2133864715 @default.
• W2316054119 cites W2148927409 @default.
• W2316054119 cites W2155831423 @default.
• W2316054119 cites W2157072273 @default.
• W2316054119 cites W2161535665 @default.
• W2316054119 cites W2162857158 @default.
• W2316054119 cites W2169304907 @default.
• W2316054119 cites W2320468565 @default.
• W2316054119 cites W4233517913 @default.
• W2316054119 cites W4245386730 @default.
• W2316054119 cites W4250078371 @default.
• W2316054119 cites W4376453368 @default.
• W2316054119 doi "https://doi.org/10.1097/md.0b013e3181f378a8" @default.
• W2316054119 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20827104" @default.
• W2316054119 hasPublicationYear "2010" @default.
• W2316054119 type Work @default.
• W2316054119 sameAs 2316054119 @default.
• W2316054119 citedByCount "76" @default.
• W2316054119 countsByYear W23160541192012 @default.
• W2316054119 countsByYear W23160541192013 @default.
• W2316054119 countsByYear W23160541192014 @default.
• W2316054119 countsByYear W23160541192015 @default.
• W2316054119 countsByYear W23160541192016 @default.
• W2316054119 countsByYear W23160541192017 @default.
• W2316054119 countsByYear W23160541192018 @default.
• W2316054119 countsByYear W23160541192019 @default.
• W2316054119 countsByYear W23160541192020 @default.
• W2316054119 countsByYear W23160541192021 @default.
• W2316054119 countsByYear W23160541192022 @default.
• W2316054119 countsByYear W23160541192023 @default.
• W2316054119 crossrefType "journal-article" @default.
• W2316054119 hasAuthorship W2316054119A5053787215 @default.
• W2316054119 hasAuthorship W2316054119A5060437184 @default.
• W2316054119 hasAuthorship W2316054119A5081450006 @default.
• W2316054119 hasAuthorship W2316054119A5091692954 @default.
• W2316054119 hasConcept C120665830 @default.
• W2316054119 hasConcept C121332964 @default.
• W2316054119 hasConcept C126322002 @default.
• W2316054119 hasConcept C141071460 @default.
• W2316054119 hasConcept C16005928 @default.
• W2316054119 hasConcept C187212893 @default.
• W2316054119 hasConcept C2778439347 @default.
• W2316054119 hasConcept C2778923028 @default.
• W2316054119 hasConcept C2779548794 @default.
• W2316054119 hasConcept C2779629538 @default.
• W2316054119 hasConcept C2780651595 @default.
• W2316054119 hasConcept C2781026528 @default.
• W2316054119 hasConcept C61511704 @default.
• W2316054119 hasConcept C71924100 @default.
• W2316054119 hasConcept C72563966 @default.
• W2316054119 hasConceptScore W2316054119C120665830 @default.
• W2316054119 hasConceptScore W2316054119C121332964 @default.
• W2316054119 hasConceptScore W2316054119C126322002 @default.
• W2316054119 hasConceptScore W2316054119C141071460 @default.
• W2316054119 hasConceptScore W2316054119C16005928 @default.
• W2316054119 hasConceptScore W2316054119C187212893 @default.
• W2316054119 hasConceptScore W2316054119C2778439347 @default.
• W2316054119 hasConceptScore W2316054119C2778923028 @default.
• W2316054119 hasConceptScore W2316054119C2779548794 @default.

• next